Gene expression of neuropeptide Y and neuropeptide-Y1 receptor in relation to proto-oncogene tyrosine kinase A, nerve-growth-factor low-affinity-receptor and the transcription factor N-myc in human neuroblastomas

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1183-1187

  Hänze, Jörg ^a   Christiansen, Holger ^a   Schüler, Daniel ^a   Worgall, Stefan ^a   Lampert, Fritz ^a   Rascher, Wolfgang ^a,b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

gene expression; LNGFR; N myc; neuroblastoma; neuropeptide Y; neuropeptide Y Y1 receptor; trkA

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0029830310     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1183     Document Type: Article

References (32)

1. Bolande RP: The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 5: 409-429, 1974.
2. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M and Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248, 1983.
3. Eisenman RN and Thompson CB: Oncogenes with potential nuclear function: myc, myb and fos. Cancer Surv 5: 309-327, 1986.
4. Tatemoto K, Carlquist M and Mutt V: Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660, 1982.
5. Adrian TE, Allen JM and Terenghi G: Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas. Lancet 1: 540-542, 1983.
6. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H and Wahlestedt C: Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267: 10935-10938, 1992.
7. Chao MV, Bothwell MA and Ross AH: Gene transfer and molecular cloning of the human NGF receptor. Science 232: 518-521, 1986.
8. Radecke MJ, Misko TP, Hsu C, Herzenberg LA and Shooter EM: Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325: 593-597, 1987.
9. Ragsdale C and Woodgett J: Neurobiology. Trking neurotrophic receptors. Nature 350: 660-661, 1991.
10. Bothwell M: Keeping track of neurotrophin receptors. Cell 65: 915-918, 1991.
11. Seeger RC, Garrett M, Brodeur MD, Sather H, Dalton A, Siegel SE, Wong KY and Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116, 1985.
12. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Brodeur GM: Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854, 1993.
13. Christiansen H, Christiansen NM, Wagner F, Altmannsberger M and Lampert F: Neuroblastoma: inverse relationship between expression of N-myc and ngf-r. Oncogene 5: 437-440, 1990.
14. Christiansen NM, Christiansen H, Berthold F and Lampert F: Transcriptional activity of N-myc and ngf-r in 50 primary human neuroblastomas as predictor for clinical outcome. Int J Oncol 3: 853-857, 1993.
15. Cohen PS, Cooper MJ, Helman LJ, Thiele CJ, Seeger RC and Israel MA: Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors. Cancer Res 50: 6055-6061, 1990.
16. Rascher W, Kremens B, Wagner S, Feth F, Hunneman H and Lang RE: Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. J Pediatr 122: 914-916, 1993.
17. Kogner P, Bjork O and Theodorss E: Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval. Acta Paediat 83: 423-427, 1994.
18. Allen JM, Martin JB and Heinrich G: Neuropeptide Y gene expression in PC12 cells and its regulation by nerve-growth-factor: a model for developmental regulation. Brain Res 427: 39-43, 1987.
19. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF and Chao MV: High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350: 660-661, 1991.
20. Kaplan DR, Martin-Zanca D and Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350: 158-160, 1991.
21. Herzog H, Baumgartner M, Vivero C, Selbie LA, Auer B and Shine J: Genomic organization, localization, and allelic differences in the gene for the human neuropeptide Y-Y1 receptor. J Biol Chem 268: 6703-6707, 1993.
22. Wahlestedt C and Reis DJ: Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Tocicol 32: 309-352, 1993.
23. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B and Seethala R: Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270: 22661-22664, 1995.
24. Feth F, Rascher W and Michel MC: G-protein coupling and signalling of Y1-like neuropeptide Y receptors in SK-N-MC cells. Naunyn-Schmied Arch Pharmacol 344: 1-7, 1991.
25. ++ mobilization in SK-N-MC cells is enhanced following isoproterenol treatment. Am J Physiol 262: E383-E388, 1992.
26. ++ mobilization by NPY. Nauyn-Schmied Arch Pharmacol 345: 370-374, 1992.
27. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Phlip T, Roald B, Sawada T, Seeger RC and Tsuchida Voute PA: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477, 1993.
28. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi B, Chiba T, Marsden HB and Misugi K: Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405-416, 1984.
29. Moos M and Gallwitz D: Structure of two human β-actin-related processed genes one of which is located next to a simple repetitive sequence. EMBO J 3: 757-761, 1983.
30. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M and Chao M: Expression and structure of the human NGF receptor. Cell 47: 545-554, 1986.
31. Minth-Worby CA: Transcriptional regulation of the human neuropeptide Y gene by nerve growth factor. J Biol Chem 269: 15460-15468, 1994.
32. Loeb DM, Maragos J, Martin-Zanca D, Chao MV, Parada LF and Greene LA: The trk protooncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 66: 961-966, 1991.